Literature DB >> 12663241

Tumor necrosis factor alpha (TNF-alpha)-induced RANTES chemokine expression via activation of NF-kappaB and p38 MAP kinase: roles of TNF-alpha in alcoholic liver diseases.

Fuminori Hirano1, Keiji Komura, Etsushi Fukawa, Isao Makino.   

Abstract

BACKGROUND/AIMS: Increased concentration of plasma tumor necrosis factor alpha (TNF-alpha) correlates with the clinical course of alcoholic liver diseases. In addition, hepatic RANTES which migrates CD4 T lymphocytes to liver is increased in patients with alcoholic hepatitis. We investigated that roles of TNF-alpha on RANTES expression in hepatocytes.
METHODS: HLE cells were treated with TNF-alpha in the presence, or absence of several inhibitors. Enzyme-linked immunoassay and reverse transcriptase-polymerase chain reaction were performed for the measurement of protein production and mRNA of RANTES, respectively. Moreover, DNA-binding activity of NF-kappaB was investigated using electrophoretic mobility shift assay. To examine effects of TNF-alpha on RANTES gene expression, luciferase assay was performed.
RESULTS: TNF-alpha clearly up-regulated RANTES expression in a time-dependent fashion and induced DNA-binding activity of NF-kappaB. Moreover, TNF-alpha-induced RANTES expression was completely inhibited by SB203580, but not calphostin C and wortmannin. Luciferase assay showed that TNF-alpha increased RANTES gene expression and mutation of NF-kappaB binding sites in the RANTES promoter ablated TNF-alpha inducibility.
CONCLUSIONS: We showed that RANTES was transcriptionally induced in human hepatoma cells by treatment with TNF-alpha via activation of NF-kappaB and p38 MAP kinase, presumably suggesting that TNF-alpha-induced expression of RANTES plays important roles in cell-mediated liver injury in alcoholic liver diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663241     DOI: 10.1016/s0168-8278(02)00456-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma.

Authors:  Hsiu-Ting Tsai; Shun-Fa Yang; Dar-Ren Chen; Szu-Erh Chan
Journal:  Med Oncol       Date:  2012-02-29       Impact factor: 3.064

2.  Ethanol augments RANTES/CCL5 expression in rat liver sinusoidal endothelial cells and human endothelial cells via activation of NF-kappa B, HIF-1 alpha, and AP-1.

Authors:  Samantha M Yeligar; Keigo Machida; Hidekazu Tsukamoto; Vijay K Kalra
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

3.  Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB.

Authors:  Jinbo Yang; Xudong Liao; Mukesh K Agarwal; Laura Barnes; Philip E Auron; George R Stark
Journal:  Genes Dev       Date:  2007-05-17       Impact factor: 11.361

4.  The effects of interleukin-18 on rat articular chondrocytes: a study of mRNA expression and protein synthesis of proinflammatory substances.

Authors:  X J Ye; B Tang; Z Ma; J Zhou; L K Myers; A H Kang; M A Cremer
Journal:  Clin Exp Immunol       Date:  2007-07-10       Impact factor: 4.330

5.  Formal reasoning on qualitative models of coinfection of HIV and Tuberculosis and HAART therapy.

Authors:  Anil Sorathiya; Andrea Bracciali; Pietro Liò
Journal:  BMC Bioinformatics       Date:  2010-01-18       Impact factor: 3.169

6.  Assessment of the RANTES Level Correlation and Selected Inflammatory and Pro-Angiogenic Molecules Evaluation of Their Influence on CRC Clinical Features: A Preliminary Observational Study.

Authors:  Sylwia Mielcarska; Agnieszka Kula; Miriam Dawidowicz; Paweł Kiczmer; Magdalena Chrabańska; Magdalena Rynkiewicz; Daria Wziątek-Kuczmik; Elżbieta Świętochowska; Dariusz Waniczek
Journal:  Medicina (Kaunas)       Date:  2022-01-28       Impact factor: 2.430

7.  Reciprocal induction of hepatitis C virus replication and stimulation of hepatic profibrogenic cytokine release and cellular viability by YKL-40.

Authors:  Du Cheng; Chengliang Zhu; Fei Liao; Liang Zhao; Lei Shen; Wenyang Jiang
Journal:  Ann Transl Med       Date:  2021-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.